- allergic reactions to the protein
- transmitting blood-borne diseases like HIV and hepatitis from contaminated donor blood
- the treatment being ineffective
- the high cost of the treatment
Human blood-clotting factors, produced by biotechnology, have greatly improved the safety of treatment for hemophiliacs by reducing the risk of:
Facebook
WhatsApp
